BioCentury
ARTICLE | Company News

Orchid, GlaxoSmithKline SNP deal

November 14, 2001 8:00 AM UTC

ORCH and GlaxoSmithKline (GSK; LSE:GSK) partnered to validate SNPs for use in pharmacogenetic studies. ORCH will develop SNP assays using human DNA panels, and is responsible for running ultra-high th...